Back
Aurinia Pharmaceuticals Stock Price Chart
Sponsored
AUPH
Sponsored
U.S. Government Report Alert Tuesday
Discover the Secret Loophole
Sell
46
AUPH
Aurinia Pharmaceuticals
Last Price:
7.21
Seasonality Move:
24.32%
7 Day Trial
ALL ACCESS PASS
$
7
Yours Free! Top SIX AI Dividend Stocks Right Now
NO CREDIT CARD REQUIRED!- The current trend is moderately bullish and AUPH is experiencing slight buying pressure.
Aurinia Pharmaceuticals Price Chart Indicators
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 7.24 | Sell |
20-day SMA: | 7.11 | Buy |
50-day SMA: | 7.03 | Buy |
200-day SMA: | 6.07 | Buy |
8-day EMA: | 7.24 | Sell |
20-day EMA: | 7.16 | Buy |
50-day EMA: | 6.91 | Buy |
200-day EMA: | 6.64 | Buy |
Aurinia Pharmaceuticals Technical Analysis Indicators
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | 0.09 | Buy |
Relative Strength Index (14 RSI): | 53.16 | Buy |
Chaikin Money Flow: | 525662 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (6.95 - 7.29) | Buy |
Bollinger Bands (100): | (5.6 - 7.08) | Buy |
Aurinia Pharmaceuticals Technical Analysis
Oct 22 | Oct 23 | Oct 24 | Oct 25 | Oct 28 | Oct 29 | Oct 30 | Oct 31 | Nov 1 | Nov 4 | |
---|---|---|---|---|---|---|---|---|---|---|
Oct | Nov | |||||||||
22 | 23 | 24 | 25 | 28 | 29 | 30 | 31 | 01 | 04 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Technical Analysis for Aurinia Pharmaceuticals Stock
Is Aurinia Pharmaceuticals Stock a Buy?
- Aurinia Pharmaceuticals share price is 7.21 while AUPH 8-day simple moving average is 7.24, which is a Sell signal.
- The stock price of AUPH is 7.21 while Aurinia Pharmaceuticals 20-day SMA is 7.11, which makes it a Buy.
- Aurinia Pharmaceuticals 50-day simple moving average is 7.03 while AUPH share price is 7.21, making it a Buy technically.
- AUPH stock price is 7.21 and Aurinia Pharmaceuticals 200-day simple moving average is 6.07, creating a Buy signal.
AUPH Technical Analysis vs Fundamental Analysis
Sell
46
Aurinia Pharmaceuticals (AUPH)
is a Sell
Is Aurinia Pharmaceuticals a Buy or a Sell?
-
Aurinia Pharmaceuticals stock is rated a Sell
The current Aurinia Pharmaceuticals [AUPH] share price is $7.21. The Score for AUPH is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
Aurinia Pharmaceuticals Stock Info
Market Cap:
1.03B
Price in USD:
7.21
Share Volume:
1.19M
Aurinia Pharmaceuticals 52-Week Range
52-Week High:
10.05
52-Week Low:
4.71
Sell
46
Aurinia Pharmaceuticals (AUPH)
is a Sell
Aurinia Pharmaceuticals Share Price Forecast
-
What is the Aurinia Pharmaceuticals stock price today?
The Aurinia Pharmaceuticals stock price is 7.21 USD today. -
Will AUPH stock go up or go down?
Aurinia Pharmaceuticals> share price is forecast to RISE/FALL based on technical indicators -
Is Aurinia Pharmaceuticals overvalued?
According to simple moving average, exponential moving average, oscillators, and other technical indicators, Aurinia Pharmaceuticals is overvalued.
Is Aurinia Pharmaceuticals Stock a Buy?
- Aurinia Pharmaceuticals share price is 7.21 while AUPH 8-day exponential moving average is 7.24, which is a Sell signal.
- The stock price of AUPH is 7.21 while Aurinia Pharmaceuticals 20-day EMA is 7.16, which makes it a Buy.
- Aurinia Pharmaceuticals 50-day exponential moving average is 6.91 while AUPH share price is 7.21, making it a Buy technically.
- AUPH stock price is 7.21 and Aurinia Pharmaceuticals 200-day simple moving average is 6.64, creating a Buy signal.
Fundamental Analysis of Aurinia Pharmaceuticals
Is Aurinia Pharmaceuticals a good investment?
- Analysts estimate an earnings increase this quarter of $0.09 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.57 per share, and an increase next year of $0.36 per share.
Technical Analysis of Aurinia Pharmaceuticals
Should I short Aurinia Pharmaceuticals stock?
- AUPH Moving Average Covergence Divergence (MACD) indicator is 0.09, suggesting Aurinia Pharmaceuticals is a Buy
- Aurinia Pharmaceuticals Relative Strength Index (RSI) is 53.16, which suggest Aurinia Pharmaceuticals is overbought
- The Bollinger Bands (25) for Aurinia Pharmaceuticals is (6.95 - 7.29), which suggest Aurinia Pharmaceuticals is a Buy
- The Bollinger Bands (100) for Aurinia Pharmaceuticals is (5.6 - 7.08), which suggest Aurinia Pharmaceuticals is a Buy
* Aurinia Pharmaceuticals stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.